Agena Bioscience® in the News

Recent Press Releases

  • Agena Bioscience Launches LungFUSION Panel for Rapid Identification of ALK, RET, and ROS1 Translocations in NSCLC Tumors More

    SAN DIEGO, March 25, 2015 /PRNewswire/ -- Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification...

  • Agena Bioscience Launches MassARRAY® 24-Well System for Affordable Genetic Testing, Liquid Biopsies More

    SAN DIEGO, Calif., Feb. 24, 2015 -- Agena Bioscience today released the MassARRAY® 24-Well System for mass spectrometry-based...

  • Agena Bioscience Appoints Peter Dansky as Chief Executive Officer More

    Life science industry executive to guide expansion of MassARRAY® platform into the clinical research and diagnostics...

  • Agena Bioscience Announces FDA 510(K) Premarket Clearance of the IMPACT Dx Factor V Leiden and Factor II Genotyping Test on the IMPACT Dx System More

    IMPACT Dx™ Combined Function System Will Also Be Available in the European Union San Diego, Calif., June 16, 2014...

  • Agena Bioscience Introduces the Hemo ID Panel for Blood Group Genotyping at the 33rd International Congress of the ISBT in Seoul, Korea More

    Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with Genotyping San Diego, Calif., June 4, 2014/PRNewswire/...

  • Sequenom, Inc.’s Bioscience Business Acquired by Agena Bioscience, a Telegraph Hill Partners Portfolio Company More

    John Lillig to Lead Agena Bioscience as Chairman and Interim CEO San Diego, Calif. – May 30, 2014 – Agena Bioscience,...

  • Agena Bioscience Aims to Advance the MassARRAY® System More

    Agena Bioscience aims to advance the MassARRAY System, a proprietary platform used in unlocking biological understanding...